Dr. Stephen Chan is a hedge fund and private equity investor at Tybourne Capital, a multi-billion dollar Tiger Grand Cub hedge fund based in Hong Kong. He oversees healthcare and life science investments at Tybourne. Before joining Tybourne Capital, Stephen was a core member of the CBC Group private equity team, one of the largest healthcare-dedicated private equity funds based in Asia. Throughout his investment career, Stephen has been involved in over 20 transactions across the healthcare value chain, totalling over $1 billion in investments. He began his career at McKinsey & Co. as a strategy consultant, advising global pharmaceutical companies on corporate and R&D strategy. Stephen holds a PhD in Genetics from the University of Cambridge, where he was also a Croucher Hong Kong Scholar, and a B.Sc. in Biochemistry from Imperial College London.
Stephen Chan
